Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALOR study: Vasopressin Loading for Refractory Septic Shock
jRCTs031230568Completed
- Start
- Jan 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial of vasopressin in septic shock (2 arms). Primary endpoint: Lactate change from baseline to 2 hours after vasopressin administration. Started Jan 2024; status: completed.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on jRCTs031230568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230568.